Beyond LDL Cholesterol, a New Role for PCSK9

被引：50
作者：
Akram, Omar N. [1 ,2 ]
Bernier, Adeline [1 ,3 ]
Petrides, Francine [1 ]
Wong, Gida [1 ,4 ]
Lambert, Gilles [1 ,5 ]
机构：
[1] Heart Res Inst, Lipid Res Grp, Sydney, NSW, Australia
[2] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia
[3] Ecole Normale Super, F-75231 Paris, France
[4] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China
[5] Univ Nantes, Fac Med, Nantes, France
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2010年 / 30卷 / 07期
关键词：
atherosclerosis; lipoproteins; metabolism; DENSITY-LIPOPROTEIN-RECEPTOR; DOMINANT HYPERCHOLESTEROLEMIA; PLASMA-CHOLESTEROL; NONHUMAN-PRIMATES; MICE; PROPROTEIN-CONVERTASE-SUBTILISIN-KEXIN-TYPE-9;
D O I：
10.1161/ATVBAHA.110.209007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1279 / 1281
页数：3
相关论文
共 50 条
  • [21] An Update on the Role of PCSK9 in Atherosclerosis
    Yurtseven, Ece
    Ural, Dilek
    Baysal, Kemal
    Tokgozoglu, Lale
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2020, 27 (09) : 909 - 918
  • [22] PCSK9: a convertase that coordinates LDL catabolism
    Horton, Jay D.
    Cohen, Jonathan C.
    Hobbs, Helen H.
    JOURNAL OF LIPID RESEARCH, 2009, 50 : S172 - S177
  • [23] An Antibody against the C-Terminal Domain of PCSK9 Lowers LDL Cholesterol Levels In Vivo
    Schiele, Felix
    Park, John
    Redemann, Norbert
    Luippold, Gerd
    Nar, Herbert
    JOURNAL OF MOLECULAR BIOLOGY, 2014, 426 (04) : 843 - 852
  • [24] Endogenous Estrogens Lower Plasma PCSK9 and LDL Cholesterol But Not Lp(a) or Bile Acid Synthesis in Women
    Persson, Lena
    Henriksson, Peter
    Westerlund, Eli
    Hovatta, Outi
    Angelin, Bo
    Rudling, Mats
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (03) : 810 - 814
  • [25] How far down to push the LDL cholesterol? PCSK9 where statins fail
    Simko, V
    Ginter, E.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2016, 117 (04): : 193 - 194
  • [26] Circulating PCSK9 levels correlate with the serum LDL cholesterol level in newborn infants
    Araki, Shunsuke
    Suga, Shutaro
    Miyake, Fuyu
    Ichikawa, Shun
    Kinjo, Tadamune
    Yamamoto, Yukiyo
    Kusuhara, Koichi
    EARLY HUMAN DEVELOPMENT, 2014, 90 (10) : 607 - 611
  • [27] PCSK9 inhibition, LDL and lipopolysaccharides: a complex and "dangerous" relationship
    Femino, Raimondo
    Femino, Giovanni
    Cavezzi, Attilio
    Troiani, Emidio
    INTERNATIONAL ANGIOLOGY, 2021, 40 (03) : 248 - 260
  • [28] PCSK9 and Atherosclerosis - Lipids and Beyond
    Shapiro, Michael D.
    Fazio, Sergio
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2017, 24 (05) : 462 - 472
  • [29] Hypercholesterolemia: The role of PCSK9
    Melendez, Quantil M.
    Krishnaji, Sreevidhya T.
    Wooten, Catherine J.
    Lopez, Dayami
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2017, 625 : 39 - 53
  • [30] Role of PCSK9 and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome
    Liu, Shuman
    Vaziri, Nosratola D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (03) : 538 - 543
12345